T82927
Azintuxizumab
TargetMol
DESCRIPTION
Azintuxizumab, an IgG4 bispecific antibody, specifically targets the B-cell maturation antigen (BCMA) and shows promise for the investigation of relapsed/refractory multiple myeloma (RRMM) [1].
DETAILS
- Cas: 1826819-57-1
- Purity: 98%
- Category: Compound
Lead Time: 4 - 5 weeks
Sign in to view pricingEquivalent Items
| ... Loading